SCHEMBL1743801

SCHEMBL1743801

C=C(NCC)NCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12018908 0.85
SCHEMBL13784687 0.83
SCHEMBL17244797 0.83
SCHEMBL20231017 0.81
SCHEMBL17244798 0.79 EGLN1 (0.42)
SCHEMBL10224697 0.79 KDM4E (0.48)
SCHEMBL27832109 0.77 ALDH1A1 (0.44)
SCHEMBL15426856 0.77 ALDH1A1 (0.39)
SCHEMBL15100636 0.76 CACNA1C (0.38)
SCHEMBL21705192 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023107696-A2 INHIBITORS OF MENIN-MLL INTERACTION BALA THERAPEUTICS, INC. (US) 2023-06-15 WO disclosed
WO-2017182108-A1 HYDROPHILICALLY MODIFIED POLYISOCYANURATE PLASTIC AND PROCESS FOR PRODUCTION THEREOF COVESTRO DEUTSCHLAND AG (DE) 2017-10-26 WO disclosed
EP-2344478-B1 CC-1065 ANALOGS AND THEIR CONJUGATES SYNTARGA BV (NL) 2017-09-27 EP disclosed
US-20150322001-A1 OMEGA-3 ANALOGUES THE UNIVERSITY OF SYDNEY (AU) 2015-11-12 US disclosed
EP-2387386-A2 BETA-AMINO ESTER COMPOUNDS AND USES THEREOF Living Proof, Inc. (US) 2011-11-23 EP disclosed
US-8040383-B2 Communication system, communication method, computer-readable medium and image shooting device FUJIFILM CORPORATION (JP) 2011-10-18 US disclosed
US-20110171291-A1 PATHOLOGICALLY-ACTIVATED THERAPEUTICS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE 2011-07-14 US disclosed
EP-2244697-A1 THERAPEUTIC COMPOSITIONS Shire Human Genetic Therapies, Inc. (US) 2010-11-03 EP disclosed
WO-2010083379-A2 BETA-AMINO ESTER COMPOUNDS AND USES THEREOF LIVING PROOF, INC. (US) 2010-07-22 WO disclosed
WO-2009097349-A1 THERAPEUTIC COMPOSITIONS SHIRE HUMAN GENETIC THERAPIES, INC. (US) 2009-08-06 WO disclosed